Answers are grounded in this paper and cite their sources.
The treatment of hepatitis C virus (HCV) has undergone significant changes within the past decade. One of these changes is the ability to treat hepatitis C with direct-acting antiviral agents (DAA) that do not involve the use of interferon.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2022) studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: